BIOCRYST PHARMACEUTICALS INC (BCRX)       10.58  -0.2 (-1.86%)

10.58  -0.2 (-1.86%)

US09058V1035 - Common Stock - After market: 10.74 +0.16 (+1.51%)

EPS Estimates (USD)

Recent Earnings VS Estimates
Period Reported Estimate Difference Surprise Q3 2022 -0.23 -0.30 0.0722.47% Q2 2022 -0.32 -0.35 0.038.62% Q1 2022 -0.40 -0.37 -0.03-7.10% Q4 2021 -0.10 -0.31 0.2167.82% Q3 2021 -0.33 -0.30 -0.03-9.92% Q2 2021 -0.24 -0.25 0.012.26% Q1 2021 -0.36 -0.28 -0.08-29.80% Q4 2020 -0.34 -0.26 -0.08-32.96%
Future EPS Estimates
Period Estimate Prior Growth (Y2Y) FY 2022 -1.13 -1.03 -9.84%Q4 2022 -0.17 -0.10 -65.06%FY 2023 -0.86 -1.13 23.82%Q1 2023 -0.27 -0.40 31.79%Q2 2023 -0.25 -0.32 21.91%Q3 2023 -0.24 -0.23 -5.33%Q4 2023 -0.25 -0.17 -52.43%FY 2024 -0.20 -0.86 77.21%Q1 2024 -0.11 -0.27 58.88%Q2 2024 -0.06 -0.25 75.51%Q3 2024 0.03 -0.24 112.63%Q4 2024 0.07 -0.25 128.38%FY 2025 0.13 -0.20 168.38%FY 2026 0.60 0.13 344.95%FY 2027 1.29 0.60 115.87%FY 2028 1.72 1.29 33.60%FY 2029 2.34 1.72 35.65%FY 2030 3.06 2.34 30.86%

Revenue Estimates (USD)

Recent Revenue VS Estimates
Period Reported Estimate Difference Surprise Q3 2022 75.827M 76.117M -290K-0.38% Q2 2022 65.532M 65.594M -62K-0.09% Q1 2022 49.923M 52.387M -2.464M-4.70% Q4 2021 47.158M 50.53M -3.372M-6.67% Q3 2021 40.994M 40.885M 109K0.27% Q2 2021 49.959M 29.245M 20.714M70.83% Q1 2021 19.06M 9.067M 9.993M110.21% Q4 2020 4.02M 15.038M -11.018M-73.27%
Future Revenue Estimates
Period Estimate Prior Growth (Y2Y) FY 2022 273.81M 157.17M 74.21%Q4 2022 78.543M 47.158M 66.55%FY 2023 363.23M 273.81M 32.66%Q1 2023 76.47M 49.923M 53.18%Q2 2023 85.323M 65.532M 30.20%Q3 2023 93.461M 75.827M 23.26%Q4 2023 103.45M 78.543M 31.71%FY 2024 452.94M 363.23M 24.70%FY 2025 561.76M 452.94M 24.03%FY 2026 646.69M 561.76M 15.12%FY 2027 792.51M 646.69M 22.55%FY 2028 930.34M 792.51M 17.39%FY 2029 1.082B 930.34M 16.30%FY 2030 1.251B 1.082B 15.62%